Maternal nutrition during pregnancy conditions the fetal pancreas development, hormonal status and diabetes mellitus and metabolic syndrome biomarkers at birth;La alimentación de la madre durante el embarazo condiciona el desarrollo pancreático, el estatus hormonal del feto y la concentración de biomarcadores al nacimiento de diabetes mellitus y síndrome metabólico

Nutricion Hospitalaria

Volumn 28, Issue 2, 2013, Pages 250-274

  Sánchez Muniz, Francisco J ^a   Gesteiro, E ^b   Esparrago Rodilla M ^b   Rodriguez Bernal B ^a   Bastida, S ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b Hospital de Merida   (Spain)

Author keywords

Fetal pancreas; Insulin sensitivity resistance biomarkers; Maternal nutrition; Neonates; Placenta; Pregnancy

Indexed keywords

ANIMALIA;

HORMONE;

ADULT; BLOOD; DIABETES MELLITUS; EATING; FEMALE; FETUS; GROWTH, DEVELOPMENT AND AGING; HUMAN; MALNUTRITION; MATERNAL NUTRITION; METABOLIC SYNDROME X; METABOLISM; PANCREAS; PHYSIOLOGY; PREGNANCY; REVIEW; COMPLICATION;

ADULT; DIABETES MELLITUS; EATING; FEMALE; FETUS; HORMONES; HUMANS; MALNUTRITION; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; METABOLIC SYNDROME X; PANCREAS; PREGNANCY;

EID: 84876993875     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2013.28.2.6307     Document Type: Review

References (173)

1. ndedition. Ergón; pp. 122-133, Madrid, 1996.
2. a edición. Editorial Médica Panamericana; pp. 151-177, Madrid, 2010.
3. ndedition. Ergón; pp. 3-28, Madrid, 1996.
4. Miras Portugal MT. Presentación. In: Pascual-Leone AM, Medina JM, eds. Desarrollo perinatal: Origen de patologías adultas, Monografía XXIII. Instituto de España. Real Academia Nacional de Farmacia; pp. 15-17; Madrid, 2008.
5. Pascual-Leone AM, Medina JM (eds). Instituto de España. Real Academia Nacional de Farmacia, Monografía XXIII. Madrid, 2008.
6. Barker DJ. Fetal origins of coronary heart disease. BMJ 1995; 311: 171-174.
7. Barker DJ. Early growth and cardiovascular disease. Arch Dis Child 1999; 80:305-307.
8. Palinski W, Napoli C. The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis. FASEB J 2002; 16:1348-1360.
9. Napoli C, Glass CK, Witztum JL, Deutsch R, D'Armiento FP, Palinski W. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: fate of Early Lesions in Children (FELIC) study. Lancet 1999; 354: 1234-1241.
10. David G, Haegel P. Embriología. En: Tuchman-Duplesis, E. ed. Cuadernos prácticos. Vol I, Toray Masson SA, Barcelona, 1970.
11. a ed., Sauders W. B, Co. Ltd. Philadelphia, Pennsylvania. 2003.
12. threvision. Geneva, 1979; 1: 763-768.
13. Bastida Codina S. Estudio "Toledo": Valores de referencia y factores de riesgo lipoproteico en neonatos. Facultad de Farmacia. Universidad Complutense de Madrid. Tesis doctoral. Madrid, 1992.
14. Espárrago Rodilla M. Estudio "La Serena": Características antropométricas y lipoproteicas de neonatos extremeños. Facultad de Farmacia. Universidad Complutense de Madrid. Tesis doctoral. Madrid, 1997.
15. Thompson JL, Manore MM, Vaughan LA. La nutrición en el ciclo vital: embarazo primer año de vida. En: Thompson JL, Manore MM, Vaughan LA, eds. Nutrición. Pearson Education SA. San Francisco, pp.716, 2008.
16. Barker DJP, Bergmnann RL, Ogra PL, eds. The window of opportunity: pre-pregnancy to 24 months of age. Karger, Nestle Nutrition Institute, pp 1-266, Basel, Switzerland, 2008
17. Herrera E. Aspectos básicos de las adaptaciones metabólicas en la madre durante la gestación y relaciones materno-fetales. En: Herrera E, ed. Bioquímica perinatal. Fundación Areces, Ceura; pp. 17-39, Madrid, 1988.
18. Herrera E, Ramos Álvarez MP. Papel del tejido adiposo, sensibilidad insulínica e ingesta lipídica en la gestación y su implicación en el riesgo de padecer diabetes en la edad adulta. In: Pascual-Leone AM, Medina JM, eds. Desarrollo perinatal: Origen de patologías adultas. Monografía XXIII. Instituto de España. Real Academia Nacional de Farmacia; pp. 205-238, Madrid, 2008.
19. Institute of Medicine, Food and Nutrition Board. Nutrition during Pregnancy, Parts I and II. Washington, DC. National Academic Press, 1990.
20. Mataix JM, Aranda Ramírez P. Gestación en Nutrición y alimentación humana. En: Mataix Verdú J, ed. II. Situaciones fisiológicas y patológicas. Ergón; pp. 1061-1084, Majadahonda, Madrid, 2009.
21. a edición. Editorial Médica Panamericana; pp. 133-149, Madrid, 2010.
22. thed. Lippincott Williams and Wilkins; pp 811-838, Phyladelphia, 1998.
23. Metzger BE, Coustan DR. Proceedings of the Fourth International Workshop-Conference on Gestational Diabetes. Diabetes Care 1998; 21 (Suppl. 2): B1-B167.
24. Aerts L, Van Assche FA. Animal evidence for the transgenerational development of diabetes mellitus. Int J Biochem Cell Biol 2006; 38: 894-903.
25. Holemans K, Aerts L, Van Assche FA. Fetal growth restriction and consequences for the offspring in animal models. J Soc Gynecol Investig 2003; 10: 292-399.
26. Aerts L, Holemans K, Van Assche FA. Maternal diabetes during pregnancy: consequences for the offspring. Diabetes Metab Rev 1990; 6: 147-167.
27. Serranos-Rios M, Reviriego J, Gutiérrez-Fuentes JA. Classification of Diabetes mellitus: Criteria for diagnosis. En: Serrano-Rios M, Gutiérrez Fuentes JA, eds. Type 2 Diabetes Mellitus. Elsevier; pp.1-23, Barcelona, 2010.
28. American Diabetes Association. Gestational diabetes mellitus (Position statement). Diabetes Care 2004; 27 (Suppl. 1): S88-S90.
29. Kervran A, Guillaume M, Jost A. The endocrine pancreas of the fetus from diabetic pregnant rat. Diabetologia 1978; 15: 387-383.
30. O'Sullivan BA, Henderson ST, Davis JM. Gestational diabetes. J Am Pharm Assoc (Wash) 1998; 38: 364-371; quiz 372-373.
31. Gesteiro E, Bastida S, Sánchez-Muniz FJ. Effects of maternal glucose tolerance, pregnancy diet quality and neonatal insulinemia upon insulin resistance/sensitivity biomarkers in normoweight neonates. Nutr Hosp 2011; 26: 1447-1455.
32. Serranos Rios M, Gutiérrez Fuentes JA. Obesity and Type 2 Diabetes Mellitus. The reciprocal impact. En: Serranos Rios M, Ordovás JM, Gutierrez Fuentes JA, eds. Obesity. Elsevier; pp. 215-232, Barcelona, 2011.
33. Solére M, Haegel P. Embriología. En: Tuchman-Duplesis E, ed. Cuadernos prácticos Vol II. Toray Masson SA, Barcelona, 1970.
34. Myatt L. Placental adaptive responses and fetal programming. J Physiol 2006; 572: 25-30.
35. Monreale de Escobar G, Obregón MJ. Consecuencias de la deprivación de iodo y hormonas tiroideas. En: Pascual-Leone AM, Medina JM, eds. Desarrollo perinatal: Origen de patologías adultas. Monografía XXIII. Instituto de España. Real Academia Nacional de Farmacia; pp. 107-130, Madrid, 2008.
36. Scholl O. Maternal Nutrition before and during pregnancy. En: Barker DJP, Bergmnann RL, Ogra PL, eds. The window of opportunity: pre-pregnancy to 24 months of age. Karger, Nestle Nutrition Institute; pp. 79-89, Basel, Switzerland, 2008.
37. Zorzano Olarte A. Utilización de glucosa durante la vida fetal y su regulación nutricional. En: Pascual-Leone AM, Medina JM, eds. Desarrollo perinatal: Origen de patologías adultas. Monografía XXIII. Instituto de España. Real Academia Nacional de Farmacia; pp. 267-301, Madrid, 2008.
38. Santalucia T, Camps M, castello A, Munoz P, Nuel A, Testar X, Palacin M, Zorzano A. Developmental regulation of GLT-1 (erythroid/Hep G2) and GLUT-4 (muscle/fat) glucose transporter expression in rat heart, skeletal muscle, and brown adipose tissue. Endocrinology 1992; 130: 837-846.
39. Santalucia T, Boheler KR, Brand NJ, Sahye U, Fandos C, Viñals F, Ferre J, Testar X, Palacin M, Zorzano A. Factors involved in GLUT-1 glucose transporter gene transcription in cardiac muscle. J Biol Chem 1999; 274: 17626-17634.
40. Larqué E, Demmelmair H, Gil-Sánchez A, Prieto-Sánchez MT, Blanco JE, Pagán A, et al. Placental transfer of fatty acids and fetal implications. Am J Clin Nutr 2011; 96 (Suppl.): 1908S-1913S.
41. Gil-Sánchez A, Koletzko B, Larqué E. Current understanding of placental fatty acid transport. Curr Opin Clin Nutr Metab Care 2012; 15: 265-272.
42. Magnusson-Olsson AL, Hamark B, Ericsson A. Gestational and hormonal regulation of human placental lipoprotein lipase. J Lipid Res 2006; 47: 2551-2561.
43. Wagner CL, Taylor SN, Dawodu A, Johnson DD, Hollis BW. Vitamin D and its role during pregnancy in attaining optimal health of mother and fetus. Nutrients 2012; 4: 208-230.
44. Christesen HT, Falkenberg T, Lamont RF, Jørgensen JS. The impact of vitamin D on pregnancy: a systematic review. Acta Obstet Gynecol Scand 2012; 901: 1357-1367.
45. a edición. Editorial Médica Panamericana; pp. 571-592, Madrid. 2010.
46. Ordovás, JM, Corella D. La revolución del genoma humano. ¿Qué significa genómica, epigenética, nutrigenética, nutrigenómica, metabolómica? En: Vaquero, MP, coordinadora. Genética, nutrición y enfermedad. Instituto Tomás Pascual y Consejo Superior de Investigaciones Científicas; pp. 17-29, Madrid, 2008.
47. Sánchez-Muniz FJ, Bastida S. Nutrigenómica y nutrigenética. Desde la expresión génica a las dietas a medida. Unidad 1. Módulo 3. In: Experto en Nutrición y Planificación Dietética. Departamento de Nutrición y Bromatología I (Nutrición). Facultad de Farmacia. Universidad Complutense de Madrid. COINSA, Madrid, 2010.
48. Sánchez-Muniz FJ, Nus M. Importancia de la interacción dietagenética en la prevención cardiovascular. Capítulo 7. En: Vaquero P, coordinadora. Genética, nutrición y enfermedad. Instituto Tomás Pascual Sanz y CSIC Editores Médicos, S.A.; pp. 125-144; Madrid, 2008.
49. Mataix Verdú J, Sánchez de Medina Contreras F. Bases metabólicas y moleculares de la nutrición. III. Regulación de la expresión génica. En: Mataix Verdú J, ed. Nutrición y alimentación humana. I. Nutrientes y alimentos. Ergón; pp. 63-69, Majadahonda, Madrid. 2009.
50. a edición. Editorial Médica; pp. 749-806, Panamericana. Madrid. 2010.
51. SEN, Departamento de Nutrición. Ingestas recomendadas de energía y nutrientes para la población Española (revisadas 2008). En: Moreiras O, Carbajal A, Cabrera L, Cuadrado C, eds. Tablas de Composición de Alimentos. Pirámide. Madrid. 2008.
52. Institute of Medicine, Food and Nutrition Board. Dietary reference intakes: The essential guide to nutrient requirements. Washington DC. National Academic Press, 2006.
53. Institute of Medicine, Food and Nutrition Board. Dietary reference intakes research synthesis workshop summary. Washington DC. National Academic Press, 2006.
54. aedición. Editorial Médica Panamericana; pp. 31-64, Madrid, 2010.
55. Ortega RM, López-Sobaler AM, Andrés P, Requejo AM, Aparicio A, Molinero LM. DIAL software for assessing diets and food calculations. Departamento de Nutrición (UCM) and Alce Ingeniería SA Madrid, 2004. http://www.alceingenieria.net/ nutricion.htm
56. FAO/WHO. The Joint FAO/WHO expert consultation on fats and fatty acids in human nutrition. FAO food and nutrition paper 91. Food and Agriculture Organization of the United Nations, Rome, 2010. ISSN 0254-4725.
57. Díaz L, Zambrano B, Chacón G, Rocha A, Diaz S. Toxoplasmosis y embarazo. Rev Obstet Ginecol Venez 2010; 70: 190-205.
58. Herrera E, Testar X, Llovera M. Efectos metabólicos del etanol. Alcohol en gestación y sus consecuencias en las relaciones feta/madre. En: Herrera E, ed. Bioquímica perinatal. Fundación Areces. Ceura; pp. 577-599, Madrid, 1988.
59. López-Tejero D, Llovera M, Herrera E. Consecuencias del alcohol durante la gestación sobre el desarrollo postnatal. En: Herrera E, ed. Bioquímica perinatal. Fundación Areces. Ceura; pp. 601-627, Madrid, 1988.
60. a edición. Editorial Médica Panamericana; pp. 735-747, Madrid, 2010.
61. Agencia Española de Seguridad Alimentaria y Sanidad (AESAN). Recomendaciones de consumo de algunas especies de pescado azul. Abril, 2011. http://www.europapress.es/ salud/noticia
62. Sánchez-Muniz FJ. Lípidos. En: García-Arias MT, García Fernández MC, eds. Nutrición y Dietética. Universidad de León. Secretariado de Publicaciones y Medios Audiovisales; pp. 119-
63. Sánchez-Muniz FJ, Mataix Verdú, J. Aceites y alimentos ricos en grasa. Unidad 5. Módulo 1 Alimentos como herramientas en la planificación dietética. En: Experto en Nutrición y Planificación Dietética. Departamento de Nutrición y Bromatología I (Nutrición). Facultad de Farmacia. Universidad Complutense. COINSA, 2007 y actualizaciones posteriores (2009, 2010, 2011). ISBN-13: 978-84-692-6575-8.
64. Larqué E, Gil-Sánchez A, Prieto-Sánchez MT, Koletko B. Omega 3 fatty acids, gestation and pregnacy otcomes. Br J Nutr 2012; 107: S77-S84.
65. a edición. Editorial Médica Panamericana; pp. 303-320, Madrid, 2010.
66. Christesen HT, Elvander C, Lamont RF, Jørgensen JS. The impact of vitamin D in pregnancy on extraskeletal health in children: A systematic review. Acta Obstet Gynecol Scand 2012; 901: 1368-1380.
67. da Rocha CM, Kac G. High dietary ratio of omega-6 to omega-3 polyunsaturated acids during pregnancy and prevalence of post-partum depression. Matern Child Nutr 2012; 8: 36-48.
68. a edición. Editorial Médica Panamericana; pp. 547-569, Madrid, 2010.
69. Rivero Urgell M. Alimentación y nutrición durante el embarazo. In: Mataix J, coordinator. Nutrición y Dietética. Aspectos sanitarios. PLENUFAR. Colegio General de Colegios Oficiales Farmacéuticos; pp. 361-379, Madrid. 1993.
70. a edición. Editorial Médica Panamericana; pp. 669-686, Madrid, 2010.
71. World Health Organization. Assessment of iodine deficiency disorders and monitoring their elimination. Department of Nutrition. Geneva, Switzerland, 2001.
72. Barbel P, Obregón MJ, Bernal J, Escobar del Rey F, Monreale de Escobar G. Iodine supplementation during pregancy: a public health challenge. Trends Endocrin Metab 2007; 18: 338-343.
73. Hoyo C, Murtha AP, Schildkraut JM, Forman MR, Calingaert B, Demark-Wahnefried W et al. Folic acid supplementation before and during pregnancy in the Newborn Epigenetics STudy (NEST). BMC Public Health 2011; 11: 46.
74. Greenberg JA, Bell SJ, Guan Y, Yu Y-H. Folic acid supplementation and pregnancy: more than just neural tube defect prevention. Rev Obstet Gynecol 2011; 4: 52-59.
75. Paz R de, Hernández Navarro F. Manejo, prevención y control de la anemia megaloblástica secundaria a déficit de ácido fólico. Nutr Hosp 2006; 21:113-119.
76. Varela-Moreiras G, Escudero JM, Aloso-Aperte E. Homocisteína, vitaminas relacionadas y estilo de vida en personas de edad avanzada: estudio Séneca. Nutr Hosp 2007; 22: 363-370.
77. a edición. Editorial Médica Panamericana; pp. 501-524, Madrid, 2010.
78. a edición. Editorial Médica Panamericana; pp. 481-500, Madrid, 2010.
79. a edición. Editorial Médica Panamericana; pp. 525-546, Madrid, 2010.
80. Sánchez-Muniz FJ. Aceite de oliva, clave de vida en la Cuenca Mediterránea. An R Ac Nac Far 2007; 73: 653-692.
81. Márquez-Sandoval F, Bulló M, Vizmanos B, Casas-Agustench P, Salas-Salvadó J. Un patrón de alimentación saludable: la dieta mediterránea tradicional. Antropo 2008; 16: 11-22.
82. Serra-Majem L, Trichopoulou A, Ngo de la Cruz J, Cervera P, García Álvarez A, La Vecchia C et al, on behalf of the International Task Force on the Mediterranean Diet. 2004 Foreword: Does the definition of the Mediterranean diet need to be updated? Public Health Nutr 2004; 7: 927-929.
83. Buckland G, Bach-Faig A, Serra-Majem L. Obesity and the Mediterranean diet: a systematic review of observational and intervention studies. Obes Rev 2008; 9: 582-593.
84. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 2003; 348: 2599-2608.
85. Trichopoulou A, Bamia C, Trichopoulos D. Mediterranean diet and survival among patients with coronary heart disease in Greece. Arch Intern Med 2005; 65: 929-935.
86. Estruch R, Martínez-González MA, Corella D, Salas-Salvadó J, Ruiz-Gutiérrez V, Covas MI et al; PREDIMED Study Investigators. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 2006; 145: 1-11.
87. Salas-Salvadó J, Bulló M, Babio N, Martínez-González MÁ, Ibarrola-Jurado N, Basora J et al; PREDIMED Study Investigators. Reduction in the incidence of type 2 diabetes with the Mediterranean diet: results of the PREDIMED-Reus nutrition intervention randomized trial. Diabetes Care 2011; 34: 14-19.
88. Gesteiro E, Rodríguez-Bernal B, Bastida S, Sánchez-Muniz FJ. Maternal diets with low healthy eating index or Mediterranean diet adherence scores are associated with high cordblood insulin levels and insulin resistance markers at birth. Eur J Clin Nutr 2012; 66: 1008-1015.
89. Kennedy ET, Ohls J, Carlson S, Fleming K. The Healthy Eating Index: design and applications. J Am Diet Assoc 1995; 95: 1103-1108.
90. Hahn CS, Rock CL, King I, Drewnowski A. Validation of de Healthy Eating Index with use of plasma biomarkers in a clinical sample of women. Am J Clin Nutr 2001; 74: 479-486.
91. Weinstein SJ, Vogt TM, Gerrior SA. Healthy Eating Index scores are associated with blood nutrient concentrations in the Third National Health and Nutrition Examination Survey. J Am Diet Assoc 2004; 104: 576-584.
92. Koning L, Chiuve SE, Fung TT, Willett WC, Rimm EB, Hu FB. Diet-quality scores and the risk of type 2 diabetes in men. Diabetes Care 2011; 34: 1150-1156.
93. McCullough ML, Feskanich D, Stampfer MJ, Giovannucci EL, Rimm EB, Hu FB et al. Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr 2002; 76: 1261-1271.
94. Bodnar LM, Siega-Riz AM. A Diet Quality Index for pregnancy detects variation in diet and difference by sociodemographic factors. Public Health Nutr 2002; 5: 801-809.
95. a edición. Editorial Médica Panamericana; pp. 171-201, Madrid, 2010.
96. Mataix Verdú J, Martínez de Victoria ME. Bases fisiológicas digestivas. I. Sistema digestivo. Bases fisiológicas. En: Mataix Verdú J, ed. Nutrición y alimentación humana. I. Nutrientes y alimentos. Ergón; pp. 5-27, Majadahonda, Madrid, 2009.
97. Mataix Verdú J, Sánchez de Medina Contreras F. Bases metabólicas y moleculares de la nutrición. I. Metabolismo y su regulación. In: Mataix Verdú J, ed. Nutrición y alimentación humana. I. Nutrientes y alimentos. Ergón; pp. 45-62, Majadahonda, Madrid. 2009.
98. a edición. Editorial Médica Panamericana; pp. 405-427, Madrid, 2010.
99. Álvarez Escolá C, Escrivá Pons F. Influencia de la subnutrición perinatal sobre el desarrollo de las células beta y la acción de la insulina: relación con la diabetes 2 adulta. En: Pascual-Leone AM, Medina JM, eds. Desarrollo perinatal: Origen de patologías adultas. Monografía XXIII, Instituto de España. Real Academia Nacional de Farmacia; pp. 239-265, Madrid, 2008.
100. Reusens B, Remacle C. Programming of the endocrine pancreas by the early nutritional environment. Int J Biochem Cell Biol 2006; 38: 913-922.
101. Poirier J, Cohen I, Baudet J, eds. Embriología humana. Versión española de Gómez Sánchez J. Editorial Marbán, Madrid. 1974.
102. Sander M, German MS. The beta cell transcription factors and development of the pancreas. J Mol Med 1997; 75: 327-340.
103. Hediger ML, Overpeck MD, McGlynn A, Kuczmarski RJ, Maurer KR, Davis WW. Growth and fatness at three to six years of age in children born with intrauterine growth retardation. J Clin Endocrinol Metab 2000; 85: 1401-1406.
104. Kaung HG. Growth dynamic of pancreatic islet cell populations during fetal and neonatal development of the rat. Dev Dyn 1994; 200: 163-175.
105. Butler AE, Cao-Minh L, Galasso R, Rizza RA, Corradin A, Cobelli C, Butler PC. Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy. Diabetologia 2010; 53: 2167-2176.
106. Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004; 429: 41-46.
107. Cordón F. La alimentación, base de la biología evolucionista. Historia natural de la acción y experiencia. Parte Primera. Origen, naturaleza y evolución del protoplasma. Alfaguara, Madrid, 1978.
108. Neel JV. Diabetes mellitus: a "thifty" genotype rendered detrimental by "progress"? Am J Hum Genet 1962; 14: 352-362.
109. Mataix Verdú J, García Torres L. Agua y equilibrio hidroelectrolítico. En: Mataix Verdú J, ed. Nutrición y alimentación humana. II. Situaciones fisiológicas y patológicas. 2nd edition. Ergón; pp 927-950, Majadahonda, Madrid, 2009.
110. ndedition. Díaz de Santos; pp 183-199, Madrid, 2005.
111. a edición. Editorial Médica Panamericana; pp. 593-621, Madrid. 2010.
112. Arellano Campos O. Percepción del sabor, dieta mediterránea y nutrigenética: efecto sobre componentes del síndrome metabólico. Doctorado en Biotecnología. Facultad de Ciencias Biológicas. Universitat de Valencia. Valencia, 2012.
113. Pedersen O. Genetics of insulin resistance. Exp Clin Endocrin Diabetes 1999; 107: 113-118.
114. Del Prato S, Pulizzi N, Lupi R, Penno G, Miccoli R. Type 2 Diabetes: Insulin resistance v. D-cell defect. En: Serranos Rios M, Gutiérrez Fuentes JA, eds. Type 2 Diabetes Mellitus. Elsevier; pp. 131-149, Barcelona, 2010.
115. Meirhaeghe A, Amoouyel P. Impact of genetic variation of PPARSgamma in humans. Mol Genet Metab 2004; 83: 93-102.
116. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S et al. Coordinated reduction of genes of oxidation metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF. Proc Natl Acad Sci USA 2003; 100: 8466-8471.
117. Jacobsson JA, Klñovins J, Kapa I, Danielsson P, Svenssson V, Ridderstråle M, et al. Novel genetic variant in FTO influenes insulin levels and insulin resistance in severely obese children and adolescents. Int J Obes (Lond) 2008; 32: 1730-1735.
118. Do R, Bailey SDS, Desbiens K, Belisle A, Montpetit A, Bouchard C et al. Genetic variants of FTO influence adiposity, insulin sensitivity, leptin levels, and resting metabolic rate in the Quebec Family Study. Diabetes 2008; 57: 1147-1150.
119. Cauchi S, El Achhab Y, Choquet H, Din C, Krempler F, Weitgasser R et al. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med 2007; 85: 777-782.
120. Florez JC. The new type 2 diabetes gene TCF7L2. Curr Opin Clin Nutr Metab Care 2007; 10: 391-396.
121. Lyssenko V, Lupi R, Marchetti P, Del Guerra S, Orho-Melander M, Almgren P et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 2007; 117: 2155-2163.
122. Londos C, Gruia-Gray J, Brasaemle DL, Rondinone CM, Takeda T, Dwyer NK et al. Perilipin: possible roles in structure and metabolism of intracellular neutral lipids in adipocytes and steroidogenic cells. Int J Obes Relat Metab Disord 1996; 20 (Suppl. 3): 97-101.
123. Martínez-Botas J, Anderson JB, Tessier D, Lapillonne A, Chang BH, Quast MJ et al. Absence of perilipin results in leenness and reverse obesity in Lepr (db/db) mice. Nat Genet 2000; 26: 474-479.
124. Sztalryd C, Xu G, Dorward H, Contreras JA, Kimmel AR, Londos C. Perilipin A is essential for the translocation of hormone-sensitive lipase during lipolytic action. J Cell Biol 2003; 161: 1093-1103.
125. Tansey JT, Sztalryd C, Gruia-Gray J, Roush DL, Zee JV, Gavrilova O et al. PLIN ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci USA 2001; 98: 6494-6499.
126. Corella D, Qi, L, Tai ES, Deurenberg M, Tan CE, Chew SK, Ordovas JM. Perilipin gene variation determines higher susceptibility to insulin resistance in Asian women when consuming a high-saturated fat, low-carbohydrate diet. Diabetes Care 2006; 29: 1313-1319.
127. Gesteiro E, Bastida S, Sánchez-Muniz FJ. Effects of APOAS S19W polymorphism on growth, insulin sensitivity and lipoproteins in normoweight neonates. Eur J Ped 2011; 170: 1551-1558.
128. Charriere S, Bernard S, Aqallal M, Merlin M, Billon S, Perrot L et al. Association of APOA5-1131T > C and S19W gene polymorphisms with both mild hypertriglyceridemia and hyperchylomicronemia in type 2 diabetic patients. Clin Chim Acta 2008; 394: 99-103.
129. Magnusson AL, Waterman IJ, Wennergren M, Jansson T, Powell TL. Triglyceride hydrolase activities and expression of fatty acid binding proteins in the human placenta in pregnancies complicated by intrauterine growth restriction and diabetes. J Clin Endocrinol Metab 2004; 89: 4607-4614.
130. Pérez-González JM, Ventura MP, Garagorri JM, Bueno-Lozano O. Retraso de crecimiento intrauterino. En: Bueno M, ed. Crecimiento y desarrollo humanos y sus trastornos. 2nd edition. Ergón; pp. 161-172, Madrid, 1996.
131. Hales CN, Barker DJP. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992; 35: 595-601.
132. Langley-Evans SC. Developmental programming of health and disease. Proc Nutr Soc 2006; 65: 97-105.
133. El-Hodhod MA, Nassar MF, Hetta OA, Gomaa SM. Pancreatic size in protein energy malnutrition: a predictor of nutritional recovery. Eur J Clin Nutr 2005; 59: 467-473.
134. Winick M, Noble A. Cellular response in rats during malnutrition at various ages. J Nutr 1996; 89: 300-306.
135. o 61. Sevilla, 2003.
136. Berney DM, Desay M, Palmer DJ, Greewald S, Brown A, Hales CN, Berry CL. The effect of maternal protein deprivation on the fetal rat pancreas: major structural changes and their recuperation. J Pathol 1997; 183: 109-115.
137. Snoeck A, Remacle C, Reusens B, Hoett JJ. Effect of low protein diet during pregnancy on the fetal rat endocrine pancreas. Biol Neonate 1990; 57: 107-118.
138. Dahri S, Snoek A, Reusens-Billen B, Remacle C, Hoett JJ. Islet function in offspring of mothers on low protein diet during gestation. Diabetes 1991; 40: 115-120.
139. Aerts L, Van Assche FA. Rat foetal endocrine pancreas in experimental diabetes. J Endocrinol 1997; 73: 339-346.
140. Hill JD, PetriK J, Arany E. Growth factors and the regulation of fetal growth. Diabetes Care 1998; 21 (Suppl. 2): 60B-69B.
141. Stanner SA, Bulmer K, Andres C, Lantseva OE, Borodina V, Poteen VV, Yudkin JS. Does malnutrition in utero determine diabetes and coronary heart disease in adulthood? Results from the Leningrade siege study. Br Med J 1997; 315: 1142-1149.
142. Lumey LH, Stein AD, Kahn HS, van der PAL-de Bruin KM, Blauw GJ, Zybert PA, Susser ES. Cohort profile: the Dutch hunger winter family study. Int J Epidemiol 2007; 36: 1196-1204.
143. a edición. Editorial Médica Panamericana; pp. 151-177, Madrid, 2010.
144. Rao RH. Diabetes in the undernourished: coincidence or consequence? Endocr Rev 1988: 9: 67-87.
145. Arantes VC, Teixeira VP, Reis MA, Latorraca MQ, Leite AR, Carneiro EM, et al. Espression of PDX-1 is reduced in pancreatic islets from pups of rat dams fed a low protein diet during gestation and lactation. J Nutr 2002; 132: 3030-3035.
146. Wilson MR, Hughes SJ. Impaired glucose-stimulated insulin release in islets from adult rats malnourished during foetalneonatal life. Mol Cell Endocrinol 1998: 142: 41-48.
147. Petersen HV, Peshavaria M, Pedersen AA, Philippe J, Stein R, Madsen OD, Serup P. Glucose stimulates the activation domain potential of the PDX-1 homeodomain transcription factor. FEBS Lett 1998; 431: 362-366.
148. MacFarlane WM, Read ML, Gilligan M, Bujalska I, Docherty K. Glucose modulates the binding activity of the beta-cell transcription factor IUF1 in a phosphorylation-dependent manner. Biochem J 1994; 303: 625-631.
149. Jonas JC, Sharma A, Hasenkamp W, Ilkova H, Patanè G, Laybutt R, et al. Increased expression of antioxidant and antiapoptotic genes in islets that may contribute to beta-cell survival during chronic hyperglycemia. Diabetes 2002; 51: 413-423.
150. Petrick J, Arany E, Mc Donald TJ, Hill DJ. Apoptosis in the pancreatic islet cells of the neonatal rat is associated with a reduced expression of insulin-like growth factor II that may act as a survival factor. Endocrinology 1998; 139: 2994-3004.
151. Petrick J, Reusens B, Arany E, Remacle C, Coelho C, Hoet JJ, Hill DJ. A low protein diet alters the balance of islet cell replication growth factor-II. Endocrinology 1999; 140: 4861-4873.
152. Arumugam R, Horowitz E, Lu D, Collier JJ, Ronnebaum S, Fleenor D, Freemark M. The interplay of prolactin and the glucocorticoids in the regulation of i-cell gene expression, fatty acid oxidation, and glucose-stimulated insulin secretion: Implications for carbohydrate metabolism in pregnancy. Endocrinolo gy 2008 149: 5401-5414.
153. Kemmitz JW, Roecker EB, Weindruch R, Elson DF, Baum ST, Bergman RN. Dietary restriction increases insulin sensitivity and lowers blood glucose in rhesus monkeys. Am J Physiol 1994; 29: E540-E547.
154. Cartee GD, Kietzke EW, Briggs-Tung C. Adaptation of muscle glucose transport with caloric restriction in adult, middleaged and olds rats. Am J Physiol 1994; 266: R1443-R1447.
155. Bowie MD. Intraveneous glucose tolerance in kwashiorkor and marasmus. S Afr Med J 1964; 38: 328-329.
156. Burger KNJ, Beulens JWJ, Boer JMA, Spijkerman AMW, van der A. DL. Dietary glycemic load and glycemic index and risk of coronary heart disease and stroke in Dutch men and women: The EPIC-MORGEN Study. PLoS One 2011; 6 (10): e25955.
157. Livesey G. A systematic review of the glycaemic response to foods and health. ILSI Europe workshop. Glycaemic response on health; pp. 82-127, Nice, France. 6-8 Dec 2006.
158. López S, Bermúdez B, Pacheco YM, Villar J, Abia R and Muriana FJG. Distinctive postprandial modulation of M-cell function and insulin sensitivity by dietary fats: monounsaturated compared with saturated fatty acids. Am J Clin Nutr 2008; 88: 638-644.
159. Smith CE, Arnett DK, Corella D, Tsai MY, Lai CQ, Parnell LD et al. Perilipin polymorphism interacts with saturated fat and carbohydrates to modulate insulin resistance. Nutr Metab Cardiovasc Dis 2012; 22: 449-455.
160. Sánchez-Muniz FJ. Dietary fiber and cardiovascular health. Nutr Hosp 2012; 27: 40-54.
161. Martín de Santa Olalla L, Sánchez-Muniz FJ, Vaquero MP. N-3 fatty acids in glucose metabolism and insulin sensitivity. Nutr Hosp 2009; 24: 203-217.
162. Herrera E, Lasunción MA. Maternal-fetal transfer of lipid metabolites. En: Polin RA, Fox WW, Abman SH, eds. Fetal and neonatal physiology. Saunders; pp 2855-2865, Philadelphia, 2004.
163. Herrera E, López-Soldado I, Limones M, Amusquivar E, Ramos MP. Lipid metabolism during the perinatal phase and its implication on postnatal development. Int J Nutr Vit Res 2006; 76: 216-224.
164. Amusquivar E, Rupérez FJ, Barbas C, Herrera E. Low arachidonic acid rather than a-tocopherol is responsible for the delayed postnatal development in offspring of rats fed fish oil instead olive oil during pregnancy and lactation. J Nutr 2000; 130: 2855-2865.
165. Gerber RT, Holemans K, O'Brien-Coker I, Mallet AI, van Bree R, Van Assche FA, Poston L. Cholesterol-independent endothelial dysfunction in virgin and pregnant rats fed a diet high in saturated fat. J Physiol 1999; 517: 607-616.
166. Guo F, Jen KL. High-fat feeding during pregnancy and lactation affects offspring metabolism in rats. Physiol Behav 1995; 57: 681-686.
167. Khan IY, Dekou V, Douglas G, Jensen R, Hanson MA. A high-fat diet during pregnancy or suckling induces cardiovascular dysfunction in adult offspring. Am J Physiol Regn Intergr Comp Physiol 2005; 288: R127-R133.
168. Ailhaud G, Guesnet P. Fatty acid composition of fats is an early determinant of childhood obesity; a short review and an opinion. Obes Rev 2004; 5: 21-26.
169. SimopouloAP. Fatty acid composition of the skeletal muscle membrane phospholipids, insulin resistance and obesity. Nutr Today 1994; 2: 12-16.
170. Serra Majem L, Aranceta Bartrina J. Alimentación infantil y juvenil. Estudio enKid. Ed. Masson. Barcelona, 2002.
171. Mataix Verdú J, Llopis González J. Manual gráfico e contenido nutricional de pratos galegos. Jiménez Contreras JF, Lendoiro Otero RM, Meniño Olivera M, eds. Consellería de Sanidad, Carrefour, Galicia, España, 1993.
172. Cervera Ral P, Fernández-Ballart D. Alimentación, embarazo y lactancia. En: Guías alimentarias para la población española. Recomendaciones para una vida saludable, SENC, IM&C, SA, pp. 355-364, Madrid, 2001.
173. Crozier SR, Robinson SM, Godfrey KM, Cooper C, Inskip HM. Women's dietary patterns change little from before to during pregnancy. J Nutr 2009; 139: 1956-1963.